Thomson Reuters, Ann Arbor, Michigan, USA.
Health Aff (Millwood). 2011 Jan;30(1):100-8. doi: 10.1377/hlthaff.2010.0896.
We evaluated the effects of implementing a value-based insurance design program for patients with diabetes in two groups within a single firm. One group participated in disease management; the other did not. We matched members of the two groups to similar enrollees within the company that did not offer the value-based program. We found that participation in both value-based insurance design and disease management resulted in sustained improvement over time. Use of diabetes medications increased 6.5 percent over three years. Adherence to diabetes medical guidelines also increased, producing a return on investment of $1.33 saved for every dollar spent during a three-year follow-up period.
我们评估了在一家公司的两个小组中实施基于价值的保险设计计划对糖尿病患者的影响。一组参与疾病管理；另一组则不参与。我们将两组的成员与公司内不提供基于价值的计划的类似参保人相匹配。我们发现，参与基于价值的保险设计和疾病管理都能随着时间的推移持续改善。三年内，糖尿病药物的使用增加了 6.5%。对糖尿病医疗指南的遵循性也有所提高，在为期三年的随访期间，每花费 1 美元就能节省 1.33 美元的投资回报。
